Purpose
to advance to WHO Pre-Qualification the development of a respiratory syncytial virus (RSV) vaccine for maternal immunization to reduce the burden of RSV disease in infants less than six months of age in developing countries
Grantee
Division
Global Health
Date
SEPTEMBER 2015
Region served
GLOBAL
Committed amount
$81,327,585
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
75
Grantee location
Gaithersburg, Maryland, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.